Literature DB >> 23133794

(18)F-FDG PET in sarcoma treatment response imaging.

Janet F Eary1, Douglas S Hawkins, Eve T Rodler, Ernest U Conrad.   

Abstract

Sarcomas are a biologically complex group of diseases that exhibit variable responses to single or combination therapy. (18)F-FDG PET imaging contributes to sarcoma treatment response assessment as an objective semiquantitative biomarker of response. In this review, background and experience in (18)F-FDG PET as a biomarker that successfully identifies tumor response is assessed.

Entities:  

Keywords:  18F-FDG PET; imaging treatment response; sarcoma

Year:  2011        PMID： 23133794      PMCID： PMC3477719     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  35 in total

Review 1.  Utility of positron emission tomography in sarcomas.

Authors:  Scott M Schuetze
Journal:  Curr Opin Oncol       Date:  2006-07       Impact factor: 3.645

Review 2.  Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.

Authors:  Gary J Kelloff; John M Hoffman; Bruce Johnson; Howard I Scher; Barry A Siegel; Edward Y Cheng; Bruce D Cheson; Joyce O'shaughnessy; Kathryn Z Guyton; David A Mankoff; Lalitha Shankar; Steven M Larson; Caroline C Sigman; Richard L Schilsky; Daniel C Sullivan
Journal:  Clin Cancer Res       Date:  2005-04-15       Impact factor: 12.531

3.  Use of 2-deoxy-2-[F-18]-fluoro-D-glucose positron emission tomography to monitor therapeutic response by rhabdomyosarcoma in children: report of a retrospective case study.

Authors:  Fangyu Peng; Galina Rabkin; Otto Muzik
Journal:  Clin Nucl Med       Date:  2006-07       Impact factor: 7.794

Review 4.  PET/CT in the evaluation of childhood sarcomas.

Authors:  M Beth McCarville; Ryan Christie; Najat C Daw; Sheri L Spunt; Sue C Kaste
Journal:  AJR Am J Roentgenol       Date:  2005-04       Impact factor: 3.959

Review 5.  Assessment of therapy response by FDG PET in pediatric patients.

Authors:  C Franzius; O Schober
Journal:  Q J Nucl Med       Date:  2003-03

6.  Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.

Authors:  Scott M Schuetze; Brian P Rubin; Cheryl Vernon; Douglas S Hawkins; James D Bruckner; Ernest U Conrad; Janet F Eary
Journal:  Cancer       Date:  2005-01-15       Impact factor: 6.860

7.  Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

Authors:  Steven M. Larson; Yusuf Erdi; Timothy Akhurst; Madhu Mazumdar; Homer A. Macapinlac; Ronald D. Finn; Cecille Casilla; Melissa Fazzari; Neil Srivastava; Henry W.D. Yeung; John L. Humm; Jose Guillem; Robert Downey; Martin Karpeh; Alfred E. Cohen; Robert Ginsberg
Journal:  Clin Positron Imaging       Date:  1999-05

8.  Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas.

Authors:  Matthias R Benz; Martin S Allen-Auerbach; Fritz C Eilber; Hui J J Chen; Sarah Dry; Michael E Phelps; Johannes Czernin; Wolfgang A Weber
Journal:  J Nucl Med       Date:  2008-09-15       Impact factor: 10.057

9.  Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas.

Authors:  Vladimir Evilevitch; Wolfgang A Weber; William D Tap; Martin Allen-Auerbach; Kira Chow; Scott D Nelson; Fredrick R Eilber; Jeffery J Eckardt; Robert M Elashoff; Michael E Phelps; Johannes Czernin; Fritz C Eilber
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

10.  18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).

Authors:  S Stroobants; J Goeminne; M Seegers; S Dimitrijevic; P Dupont; J Nuyts; M Martens; B van den Borne; P Cole; R Sciot; H Dumez; S Silberman; L Mortelmans; A van Oosterom
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162
View more
  27 in total

Review 1.  Incremental Value of FDG-PET in the Evaluation of Cardiac Masses.

Authors:  Patrick Martineau; Vasken Dilsizian; Matthieu Pelletier-Galarneau
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

Review 2.  Quantum dot-based nanoprobes for in vivo targeted imaging.

Authors:  Y Zhu; H Hong; Z P Xu; Z Li; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 3.  Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.

Authors:  T R Nayak; H Hong; Y Zhang; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 4.  Functionalized upconversion nanoparticles: versatile nanoplatforms for translational research.

Authors:  F Chen; W Bu; W Cai; J Shi
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 5.  Biomedical applications of zinc oxide nanomaterials.

Authors:  Y Zhang; T R Nayak; H Hong; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 6.  Antibody-based imaging of HER-2: moving into the clinic.

Authors:  R E Wang; Y Zhang; L Tian; W Cai; J Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

7.  In a "nutshell": intrinsically radio-labeled quantum dots.

Authors:  Weibo Cai; Hao Hong
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

8.  In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene.

Authors:  Hao Hong; Yin Zhang; Jonathan W Engle; Tapas R Nayak; Charles P Theuer; Robert J Nickles; Todd E Barnhart; Weibo Cai
Journal:  Biomaterials       Date:  2012-03-03       Impact factor: 12.479

9.  Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.

Authors:  Yin Zhang; Hao Hong; Tapas R Nayak; Hector F Valdovinos; Duane V Myklejord; Charles P Theuer; Todd E Barnhart; Weibo Cai
Journal:  Angiogenesis       Date:  2013-03-08       Impact factor: 9.596

10.  Tumor vasculature targeting and imaging in living mice with reduced graphene oxide.

Authors:  Sixiang Shi; Kai Yang; Hao Hong; Hector F Valdovinos; Tapas R Nayak; Yin Zhang; Charles P Theuer; Todd E Barnhart; Zhuang Liu; Weibo Cai
Journal:  Biomaterials       Date:  2013-01-29       Impact factor: 12.479
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.